ConductScience.org, home

Paper4856629

Structure-antitumor activity relationships among quinone derivatives.

Driscoll JS and 3 others. Cancer Chemother Rep 2, 1974. Cited by 71 papers, by iCite.

Cite this record

ConductScience Library. Structure-antitumor activity relationships among quinone derivatives. Papers, record 4856629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4856629

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure-antitumor activity relationships among quinone derivatives.
PubMed
Journal
Cancer Chemother Rep 2
PubMed
Year
1974
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
71
iCite
Relative citation ratio, by iCite
3.04
iCite
Revised in PubMed
2016-11-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Driscoll JSJ S
2Hazard GF JrG F
3Wood HB JrH B
4Goldin AA

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
QuinonesMajor topic
Animals
Anthraquinones
Azirines
Bridged-Ring Compounds
Carcinoma 256, Walker
Daunorubicin
Drug Evaluation, Preclinical
Heterocyclic Compounds
L-Lactate Dehydrogenase
Leukemia L1210
Mice
Mitomycins
Naphthoquinones
Neoplasms, Experimental
Sarcoma 180
Streptonigrin
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.

PMIDTitleJournalYearIn PapersSource
36570217Nanotherapeutic Intervention in Photodynamic Therapy for Cancer.ACS Omega2022https://conductscience.org/library/papers/36570217PubMed
33519476Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity.Front Pharmacol2020https://conductscience.org/library/papers/33519476PubMed
32318101Antioxidant Properties of Lapachol and Its Derivatives and Their Ability to Chelate Iron (II) Cation: DFT and QTAIM Studies.Bioinorg Chem Appl2020https://conductscience.org/library/papers/32318101PubMed
30959841Juglone in Oxidative Stress and Cell Signaling.Antioxidants (Basel)2019https://conductscience.org/library/papers/30959841PubMed
30689661Lapachol and synthetic derivatives: in vitro and in vivo activities against Bothrops snake venoms.PLoS One2019https://conductscience.org/library/papers/30689661PubMed
29651389The Healing Effect of N-Hexan- Dichloromethane Extract Root Onosma Bulbotrichum in Second Degree Burns.World J Plast Surg2018https://conductscience.org/library/papers/29651389PubMed
212019312,3-Bis(2-chloro-benz-yl)naphthalene-1,4-dione.Acta Crystallogr Sect E Struct Rep Online2008https://conductscience.org/library/papers/21201931PubMed
9559016Unconventional therapies for cancer: 1. Essiac. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.CMAJ1998https://conductscience.org/library/papers/9559016PubMed
7196864The immunoinhibitory and immunostimulatory effects of hydroxyanthra- and hydroxynaphthoquinone derivatives.Folia Microbiol (Praha)1981https://conductscience.org/library/papers/7196864PubMed
6819097Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/6819097PubMed
6584903Mutagenicity of quinones: pathways of metabolic activation and detoxification.Proc Natl Acad Sci U S A1984https://conductscience.org/library/papers/6584903PubMed
6381377Diaziquone (AZQ).Invest New Drugs1983https://conductscience.org/library/papers/6381377PubMed
4056853Phase II evaluation of diaziquone (CI-904, AZQ) in the treatment of human malignant glioma.J Neurooncol1985https://conductscience.org/library/papers/4056853PubMed
4005142Selective toxicity of 1-naphthol to human colorectal tumour tissue.Br J Cancer1985https://conductscience.org/library/papers/4005142PubMed
3965159Human pharmacokinetics of marcellomycin.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/3965159PubMed
3838738Stability of 2,5-diaziridinyl-3,6-bis(2-hydroxyethylamino)-1,4-benzoquinone (BZQ; NSC 224070) in aqueous solutions by high-performance liquid chromatography.Invest New Drugs1985https://conductscience.org/library/papers/3838738PubMed
3746385Response variability of human brain tumors to AZQ in tissue culture.J Neurooncol1986https://conductscience.org/library/papers/3746385PubMed
3700042High dose AZQ in renal cancer. A Southwest Oncology Group phase II study.Invest New Drugs1986https://conductscience.org/library/papers/3700042PubMed
3307874Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?Br J Cancer Suppl1987https://conductscience.org/library/papers/3307874PubMed
2993536Phase II study of aziridinylbenzoquinone (AZQ) in patients with central nervous system malignancies: a Southwest Oncology Group Study.J Neurooncol1985https://conductscience.org/library/papers/2993536PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4856629

GET https://conductscience.org/api/papers/v1/4856629/cited_by?page=2